The relationship between MICU2 and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of October 19, 2023. MICU2 encodes mitochondrial calcium uptake protein 2. This is a subunit of the mitochondrial uniporter complex, a multi-subunit calcium channel of the mitochondrial inner membrane. MICU2 is involved in calcium import into the mitochondrion and negative regulation of mitochondrial calcium ion concentration by regulating calcium channel opening.
The MICU2 gene has been reported in relation to autosomal recessive primary mitochondrial disease in one case to date in 2017 (PMID: 29053821). This was an 11-year-old girl with cognitive delay and intellectual disability. Brain MRI showed gliosis and T2 hyperintense foci in both cerebral hemisphere in a subcortical distribution. She had a similarly affected brother who also had abnormal eye movements. Although the phenotype is nonspecific, there was a homozygous nonsense variant in MICU2 present in these two siblings, and given the calcium flux abnormalities noted in patient cells, this GCEP elected to include this family in this curation. While various names could be given to the constellation of features seen in those with MICU2-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the MICU2 phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework.
Evidence supporting this gene-disease relationship includes case-level data and experimental data. As described above, this curation includes one proband with a homozygous nonsense variant from one publication (PMID: 29053821).
This gene-disease association is also supported by the known biochemical function of MICU2 that is shared with MICU1, a gene with a definitive association to primary mitochondrial disease (PMID: 26903221). It is also supported by experimental data including mitochondrial calcium uptake studies with either shRNA or siRNA knockdown in HeLa cells (PMIDs: 26903221, 24560927) and knockout mice (PMID: 29073106).
In summary, there is limited evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on October 19, 2023 (SOP Version 9).
The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.